Skip to main content
Top
Published in: Archives of Virology 8/2018

01-08-2018 | Brief Report

Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017

Authors: Yufan Xu, Xiaorong Peng, Xiuming Peng, Shujing Ji, Bin Chen, Liyan Wang, Xiangyun Lu, Tiansheng Xie, Tao Sun, Hui Wang, Nanping Wu

Published in: Archives of Virology | Issue 8/2018

Login to get access

Abstract

In recent years, transmitted drug resistance (TDR) has adversely impacted upon first-line therapy for HIV-infected individuals. To understand the current subtype distribution and TDR level in Zhejiang, China we performed phylogenetic analysis and genotypic drug resistance testing of treatment-naive HIV-infected individuals. A total of 153 HIV-1 Pol genes were successfully amplified. The distribution of HIV-1 genotypes was as follows: CRF01_AE (43.8%); CRF07_BC (37.9%); subtype B/B’ (7.2%); CRF08_BC (5.2%); and others (5.9%). Drug resistance analysis demonstrated that 11.1% of isolates contained at least one NRTI or NNRTI resistance-associated mutations while 2.0% were identified to be resistant to PIs. These findings enhance our understanding of the genetic diversity of HIV-1 strains circulating in Zhejiang and provide some guidelines for HIV initial treatment therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ (2001) Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 135:17–26CrossRefPubMed Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ (2001) Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med 135:17–26CrossRefPubMed
2.
go back to reference Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO (2002) Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 288:181–188CrossRefPubMed Grant RM, Hecht FM, Warmerdam M, Liu L, Liegler T, Petropoulos CJ, Hellmann NS, Chesney M, Busch MP, Kahn JO (2002) Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 288:181–188CrossRefPubMed
3.
go back to reference Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD (2008) Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis 47:266–285CrossRefPubMed Hirsch MS, Günthard HF, Schapiro JM, Brun-Vézinet F, Clotet B, Hammer SM, Johnson VA, Kuritzkes DR, Mellors JW, Pillay D, Yeni PG, Jacobsen DM, Richman DD (2008) Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis 47:266–285CrossRefPubMed
4.
go back to reference Taiwo B (2009) Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis 13:552–559CrossRefPubMed Taiwo B (2009) Understanding transmitted HIV resistance through the experience in the USA. Int J Infect Dis 13:552–559CrossRefPubMed
5.
go back to reference Avila-Rios S, Sued O, Rhee SY, Shafer RW, Reyes-Teran G, Ravasi G (2016) Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS One 11:e0158560CrossRefPubMedPubMedCentral Avila-Rios S, Sued O, Rhee SY, Shafer RW, Reyes-Teran G, Ravasi G (2016) Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS One 11:e0158560CrossRefPubMedPubMedCentral
6.
go back to reference Sui H, Gui T, Jia L, Guo W, Han J, Liu Y, Bao Z, Li H, Li J, Li L (2014) Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study. PLoS One 9:e91803CrossRefPubMedPubMedCentral Sui H, Gui T, Jia L, Guo W, Han J, Liu Y, Bao Z, Li H, Li J, Li L (2014) Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study. PLoS One 9:e91803CrossRefPubMedPubMedCentral
7.
go back to reference Li X, Li W, Zhong P, Fang K, Zhu K, Musa TH, Song Y, Du G, Gao R, Guo Y, Yan W, Xuan Y, Wei P (2016) Nationwide trends in molecular epidemiology of HIV-1 in China. AIDS Res Hum Retrovir 32:851–859CrossRefPubMed Li X, Li W, Zhong P, Fang K, Zhu K, Musa TH, Song Y, Du G, Gao R, Guo Y, Yan W, Xuan Y, Wei P (2016) Nationwide trends in molecular epidemiology of HIV-1 in China. AIDS Res Hum Retrovir 32:851–859CrossRefPubMed
8.
go back to reference Wu J, Meng Z, Xu J, Lei Y, Jin L, Zhong P, Han R, Su B (2013) New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. PLoS One 8:e54322CrossRefPubMedPubMedCentral Wu J, Meng Z, Xu J, Lei Y, Jin L, Zhong P, Han R, Su B (2013) New emerging recombinant HIV-1 strains and close transmission linkage of HIV-1 strains in the Chinese MSM population indicate a new epidemic risk. PLoS One 8:e54322CrossRefPubMedPubMedCentral
9.
go back to reference Chen L, Pan X, Ma Q, Yang J, Xu Y, Zheng J, Wang H, Zhou X, Jiang T, Jiang J, He L, Jiang J (2017) HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006-2013. Sci Rep 7:42366CrossRefPubMedPubMedCentral Chen L, Pan X, Ma Q, Yang J, Xu Y, Zheng J, Wang H, Zhou X, Jiang T, Jiang J, He L, Jiang J (2017) HIV cause-specific deaths, mortality, risk factors, and the combined influence of HAART and late diagnosis in Zhejiang, China, 2006-2013. Sci Rep 7:42366CrossRefPubMedPubMedCentral
10.
go back to reference Zhao B, Han X, Xu J, Hu Q, Chu Z, Zhang J, Lu L, Wang Z, Fu J, Chen X, Yan H, Zhuang M, Wang L, Sun A, Zhang CM, Shang H (2015) Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China. J Acquir Immune Defic Syndr 68:250–255CrossRefPubMed Zhao B, Han X, Xu J, Hu Q, Chu Z, Zhang J, Lu L, Wang Z, Fu J, Chen X, Yan H, Zhuang M, Wang L, Sun A, Zhang CM, Shang H (2015) Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China. J Acquir Immune Defic Syndr 68:250–255CrossRefPubMed
11.
go back to reference Yao Y, Xin R, Yang J, Xu Y, Zhang J, Xia Y, Pan X, Guo Z, Song Y (2015) Trends of subtype variation of human immunodeficiency virus type 1 in Zhejiang Province, China. Virus Genes 50:22–28CrossRefPubMed Yao Y, Xin R, Yang J, Xu Y, Zhang J, Xia Y, Pan X, Guo Z, Song Y (2015) Trends of subtype variation of human immunodeficiency virus type 1 in Zhejiang Province, China. Virus Genes 50:22–28CrossRefPubMed
12.
go back to reference Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347:385–394CrossRefPubMed Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD (2002) Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 347:385–394CrossRefPubMed
13.
go back to reference Lai CC, Hung CC, Chen MY, Sun HY, Lu CL, Tseng YT, Chang SF, Su YC, Liu WC, Hsieh CY, Wu PY, Chang SY, Chang SC (2012) Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan. J Antimicrob Chemother 67:1254–1260CrossRefPubMed Lai CC, Hung CC, Chen MY, Sun HY, Lu CL, Tseng YT, Chang SF, Su YC, Liu WC, Hsieh CY, Wu PY, Chang SY, Chang SC (2012) Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan. J Antimicrob Chemother 67:1254–1260CrossRefPubMed
14.
go back to reference Li JF, Linley L, Kline R, Ziebell R, Heneine W, Johnson JA (2016) Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups. AIDS 30:1439–1445CrossRefPubMed Li JF, Linley L, Kline R, Ziebell R, Heneine W, Johnson JA (2016) Sensitive sentinel mutation screening reveals differential underestimation of transmitted HIV drug resistance among demographic groups. AIDS 30:1439–1445CrossRefPubMed
15.
go back to reference Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P (2011) HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis 52:1053–1057CrossRefPubMedPubMedCentral Sungkanuparph S, Oyomopito R, Sirivichayakul S, Sirisanthana T, Li PC, Kantipong P, Lee CK, Kamarulzaman A, Messerschmidt L, Law MG, Phanuphak P (2011) HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring Study. Clin Infect Dis 52:1053–1057CrossRefPubMedPubMedCentral
Metadata
Title
Characterization of HIV-1 subtypes and transmitted drug resistance among treatment-naive HIV-infected individuals in Zhejiang, China, 2014-2017
Authors
Yufan Xu
Xiaorong Peng
Xiuming Peng
Shujing Ji
Bin Chen
Liyan Wang
Xiangyun Lu
Tiansheng Xie
Tao Sun
Hui Wang
Nanping Wu
Publication date
01-08-2018
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2018
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-018-3839-1

Other articles of this Issue 8/2018

Archives of Virology 8/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.